COMMUNIQUÉS West-GlobeNewswire

Alder BioPharmaceuticals® to Present at Two Upcoming May Investor Conferences
14/05/2019
BOTHELL, Wash., May 14, 2019 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]
electroCore Announces First Quarter 2019 Financial Results
14/05/2019
Continues to deliver sequential growth in covered lives, prescribing physicians and FSS facilities Company to host conference call and webcast today, May 14, at 4:30pm ET BASKING RIDGE, N.J., May 14, 2019 (GLOBE [...]
Quotient Limited to Report Fiscal Fourth Quarter and Full Year 2019 Financial Results and Host Conference Call
14/05/2019
JERSEY, Channel Islands, May 14, 2019 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal fourth quarter and full year ended [...]
Kezar Life Sciences Announces Presentations at Two Upcoming Investor Conferences
14/05/2019
SOUTH SAN FRANCISCO, Calif., May 14, 2019 (GLOBE NEWSWIRE) -- Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing novel small molecule therapeutics to treat unmet [...]
Scholar Rock Reports First Quarter 2019 Financial Results and Highlights Business Progress
14/05/2019
Commenced patient enrollment and dosing in TOPAZ, the Phase 2 clinical trial for SRK-015 in Type 2 and Type 3 Spinal Muscular Atrophy (SMA) Presented additional preclinical data from the SRK-181 cancer immunotherapy [...]
Cyclacel Pharmaceuticals Reports First Quarter 2019 Financial Results
14/05/2019
Conference Call Scheduled May 14, 2019 at 4:30 p.m. ET BERKELEY HEIGHTS, N.J., May 14, 2019 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a [...]
Zosano Pharma Reports First Quarter 2019 Financial Results
14/05/2019
Multiple catalysts, including Qtrypta TM NDA submission, anticipated in 2019 Company bolstered balance sheet to advance proprietary programs and expand applicability of ADAM microneedle technology Conference call [...]
Principia Biopharma Announces First Patient Dosed in Sanofi’s Phase 2b Trial of SAR442168 in Multiple Sclerosis, Triggering $30 Million Milestone
14/05/2019
SOUTH SAN FRANCISCO, Calif., May 14, 2019 (GLOBE NEWSWIRE) -- Principia Biopharma Inc. (Nasdaq: PRNB), a late-stage biopharmaceutical company dedicated to bringing transformative oral therapies to patients with [...]
Codexis to Participate at Three Investment Conferences in May
14/05/2019
REDWOOD CITY, Calif., May 14, 2019 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces that management will participate in three upcoming investment conferences: UBS Global [...]
KemPharm Reports First Quarter 2019 Results
14/05/2019
Development & Regulatory Highlights: Completed KP415 Pre-NDA Meeting with FDA Provided Update on APADAZ ® Formulary Adoption Announced FDA Approval of sNDA for Two Additional Strengths of APADAZ Corporate & [...]
TRACON Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Corporate Update
14/05/2019
SAN DIEGO, May 14, 2019 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, [...]
Genesis HealthCare to Present at 2019 RBC Capital Markets Global Healthcare Conference
14/05/2019
KENNETT SQUARE, Pa., May 14, 2019 (GLOBE NEWSWIRE) -- Genesis Healthcare, Inc. (Company) (NYSE:GEN), one of the largest post-acute care providers in the United States, today announced that George V. Hager, Jr., Chief [...]
OpGen Reports First Quarter 2019 Financial Results and Provides Business Update
14/05/2019
Submission of 510(k) application to the FDA for clearance of the Acuitas ® AMR Gene Panel test for bacterial isolates Revenue up 21% Quarter-over-Quarter Conference call to be held at 4:30 p.m. Eastern time today [...]
Acer Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update
14/05/2019
Acer executing on pre-commercial launch plan for EDSIVO™ while growing and advancing its pipeline NEWTON, Mass., May 14, 2019 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused [...]
Daré Bioscience Reports First Quarter 2019 Financial Results and Company Update
14/05/2019
SAN DIEGO, May 14, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today reported financial results for the first quarter ended March 31, 2019 and provided a Company [...]
Capital Increase in Genmab as a Result of Employee Warrant Exercise
14/05/2019
Company Announcement Copenhagen, Denmark; May 14, 2019 – Genmab A/S (Nasdaq Copenhagen: GEN) will increase its share capital by 9,737 shares as a consequence of the exercise of employee warrants. The increase is [...]
Chapin Aesthetics Begins Offering Microneedling and PRP for the Philadelphia Area
14/05/2019
2019 marks the debut of a skin-revitalizing treatment offered by Dr. Scott D. Chapin and his team DOYELSTOWN, Pa., May 14, 2019 (GLOBE NEWSWIRE) -- As a plastic surgeon in the Philadelphia area , Dr. Scott D. Chapin has [...]
During Skin Cancer Awareness Month, Dermatologists Share 5 Common Sunscreen Mistakes — and How to Avoid Them; American Academy of Dermatology
14/05/2019
ROSEMONT, Ill., May 14, 2019 (GLOBE NEWSWIRE) -- Skin cancer is the most common cancer in the United States, affecting one in five Americans in their lifetime. Yet according to dermatologists from the American Academy [...]
Tauriga Sciences Inc. to Commence Initial Production Run of Blood Orange Flavored Version of Tauri-Gum
14/05/2019
New York, NY, May 14, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, and [...]

Pages